Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting the nigrostriatal pathway, where patients do not manifest motor symptoms until >50% of neurons are lost. Thus, it is of great importance to determine early neuronal changes that may contribute to disease progression. Recent attention has focused on lipids and their role in pro- and anti-apoptotic processes. Howeve
BACKGROUND: We present a lipidomics analysis of human Parkinson's disease tissues. We have focused o...
Parkinson’s disease (PD) risk gene discoveries have implicated lipids and inflammation in pathology....
With increasing prevalence, Parkinson’s disease presents a major challenge for medical research and ...
Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting the nigrostriatal pat...
Abstract: Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting the nigrostr...
Parkinson’s disease (PD) is a complex and progressive neurodegenerative disorder with a prevalence o...
Introduction: Current markers of Parkinson's disease (PD) fail to detect the early progression of di...
BackgroundParkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pa...
Introduction Current markers of Parkinson’s disease (PD) fail to detect the early progression of di...
Parkinson’s disease (PD) is a neurodegenerative disease characterized by a progressive loss of...
Parkinson’s disease (PD) is the second most common neurodegenerative disease, the main pathological ...
Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder, pathologically chara...
Contains fulltext : 202273.pdf (publisher's version ) (Open Access)Parkinson's dis...
Parkin mutations are a major cause of early-onset Parkinson's disease (PD). The impairment of protei...
Lipid metabolism is clearly associated to Parkinson’s disease (PD). Although lipid homeostasis has b...
BACKGROUND: We present a lipidomics analysis of human Parkinson's disease tissues. We have focused o...
Parkinson’s disease (PD) risk gene discoveries have implicated lipids and inflammation in pathology....
With increasing prevalence, Parkinson’s disease presents a major challenge for medical research and ...
Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting the nigrostriatal pat...
Abstract: Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting the nigrostr...
Parkinson’s disease (PD) is a complex and progressive neurodegenerative disorder with a prevalence o...
Introduction: Current markers of Parkinson's disease (PD) fail to detect the early progression of di...
BackgroundParkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pa...
Introduction Current markers of Parkinson’s disease (PD) fail to detect the early progression of di...
Parkinson’s disease (PD) is a neurodegenerative disease characterized by a progressive loss of...
Parkinson’s disease (PD) is the second most common neurodegenerative disease, the main pathological ...
Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder, pathologically chara...
Contains fulltext : 202273.pdf (publisher's version ) (Open Access)Parkinson's dis...
Parkin mutations are a major cause of early-onset Parkinson's disease (PD). The impairment of protei...
Lipid metabolism is clearly associated to Parkinson’s disease (PD). Although lipid homeostasis has b...
BACKGROUND: We present a lipidomics analysis of human Parkinson's disease tissues. We have focused o...
Parkinson’s disease (PD) risk gene discoveries have implicated lipids and inflammation in pathology....
With increasing prevalence, Parkinson’s disease presents a major challenge for medical research and ...